white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://www.drugdiscoverytrends.com/wp-content/uploads/2025/11/trump.webp)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://c.firstwordpharma.com/firstwordgroup/assets/images/obesity_cost_burden.jpeg)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://static.independent.co.uk/2026/02/06/0/22/SEI283706526.jpg)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1630682044/WhiteHouse-uschools%3AiStock%3AGetty%20Images%20Plus%3AGetty%20Images.jpg/WhiteHouse-uschools%3AiStock%3AGetty%20Images%20Plus%3AGetty%20Images.jpg?VersionId=ZsfkkglMOpYnBBlmwvn_38AS9er6MvkB)

















/assets/images/provider/photos/2805921.jpeg)





